ID   GC76C_DROME             Reviewed;        1525 AA.
AC   Q7JQ32; Q24051;
DT   06-JUL-2016, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   07-APR-2021, entry version 161.
DE   RecName: Full=Receptor-type guanylate cyclase Gyc76C {ECO:0000305};
DE            EC=4.6.1.2 {ECO:0000255, ECO:0000255|RuleBase:RU003431, ECO:0000269|PubMed:24284209};
DE   AltName: Full=DrGC-1 {ECO:0000303|PubMed:7706258};
DE   Flags: Precursor;
GN   Name=Gyc76C {ECO:0000312|FlyBase:FBgn0266136};
GN   ORFNames=CG42636 {ECO:0000312|FlyBase:FBgn0266136};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227 {ECO:0000312|EMBL:AAA74408.1};
RN   [1] {ECO:0000312|EMBL:AAA74408.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], AND DEVELOPMENTAL STAGE.
RX   PubMed=7706258; DOI=10.1074/jbc.270.13.7189;
RA   McNeil L., Chinkers M., Forte M.;
RT   "Identification, characterization, and developmental regulation of a
RT   receptor guanylyl cyclase expressed during early stages of Drosophila
RT   development.";
RL   J. Biol. Chem. 270:7189-7196(1995).
RN   [2] {ECO:0000312|EMBL:AAA85858.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=7759483; DOI=10.1074/jbc.270.21.12418;
RA   Liu W., Yoon J., Burg M., Chen L., Pak W.L.;
RT   "Molecular characterization of two Drosophila guanylate cyclases expressed
RT   in the nervous system.";
RL   J. Biol. Chem. 270:12418-12427(1995).
RN   [3] {ECO:0000312|Proteomes:UP000000803}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4] {ECO:0000312|Proteomes:UP000000803}
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5] {ECO:0000312|EMBL:AAR31133.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley {ECO:0000312|EMBL:AAR31133.1};
RC   TISSUE=Embryo {ECO:0000312|EMBL:AAR31133.1};
RA   Stapleton M., Brokstein P., Hong L., Agbayani A., Carlson J., Champe M.,
RA   Chavez C., Dorsett V., Dresnek D., Farfan D., Frise E., George R.,
RA   Gonzalez M., Guarin H., Kronmiller B., Li P., Liao G., Miranda A.,
RA   Mungall C.J., Nunoo J., Pacleb J., Paragas V., Park S., Patel S.,
RA   Phouanenavong S., Wan K., Yu C., Lewis S.E., Rubin G.M., Celniker S.;
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305}
RP   FUNCTION, DOMAIN, AND DISRUPTION PHENOTYPE.
RX   PubMed=15282266; DOI=10.1523/jneurosci.1104-04.2004;
RA   Ayoob J.C., Yu H.H., Terman J.R., Kolodkin A.L.;
RT   "The Drosophila receptor guanylyl cyclase Gyc76C is required for
RT   semaphorin-1a-plexin A-mediated axonal repulsion.";
RL   J. Neurosci. 24:6639-6649(2004).
RN   [7] {ECO:0000305}
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=23213443; DOI=10.1242/bio.2012943;
RA   Patel U., Davies S.A., Myat M.M.;
RT   "Receptor-type guanylyl cyclase Gyc76C is required for development of the
RT   Drosophila embryonic somatic muscle.";
RL   Biol. Open 1:507-515(2012).
RN   [8] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=21893139; DOI=10.1016/j.peptides.2011.08.019;
RA   Overend G., Cabrero P., Guo A.X., Sebastian S., Cundall M., Armstrong H.,
RA   Mertens I., Schoofs L., Dow J.A., Davies S.A.;
RT   "The receptor guanylate cyclase Gyc76C and a peptide ligand, NPLP1-VQQ,
RT   modulate the innate immune IMD pathway in response to salt stress.";
RL   Peptides 34:209-218(2012).
RN   [9] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=23862019; DOI=10.1242/bio.20134887;
RA   Patel U., Myat M.M.;
RT   "Receptor guanylyl cyclase Gyc76C is required for invagination, collective
RT   migration and lumen shape in the Drosophila embryonic salivary gland.";
RL   Biol. Open 2:711-717(2013).
RN   [10] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, INTERACTION WITH KERMIT
RP   AND PLEXA, AND MUTAGENESIS OF ASP-945.
RX   PubMed=24284209; DOI=10.1242/dev.095968;
RA   Chak K., Kolodkin A.L.;
RT   "Function of the Drosophila receptor guanylyl cyclase Gyc76C in PlexA-
RT   mediated motor axon guidance.";
RL   Development 141:136-147(2014).
RN   [11] {ECO:0000305}
RP   FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF LEU-635.
RX   PubMed=26440503; DOI=10.1371/journal.pgen.1005576;
RA   Schleede J., Blair S.S.;
RT   "The Gyc76C receptor guanylyl cyclase and the foraging cGMP-dependent
RT   kinase regulate extracellular matrix organization and BMP signaling in the
RT   developing wing of Drosophila melanogaster.";
RL   PLoS Genet. 11:E1005576-E1005576(2015).
CC   -!- FUNCTION: Guanylate cyclase involved in the production of the second
CC       messenger cGMP (PubMed:24284209). Acts as a receptor for the NPLP1-4
CC       peptide and modulates the innate immune IMD pathway in response to salt
CC       stress by inducing nuclear translocation of NF-kappa-B protein Rel
CC       which leads to increased expression of the antimicrobial peptide
CC       diptericin (PubMed:21893139). Plays a role in Sema-1a-mediated axon
CC       repulsion which is required for the correct establishment of
CC       neuromuscular connectivity (PubMed:15282266, PubMed:24284209). Required
CC       in developing embryonic somatic muscle for correct patterning of
CC       ventral and lateral muscles and for localization of integrin beta-ps at
CC       developing dorsal muscle myotendinous junctions (PubMed:23213443).
CC       Required for invagination, migration and lumen shape of the embryonic
CC       salivary gland by regulating the localization of the integrin-binding
CC       protein rhea/Talin to the visceral mesoderm surrounding the gland and
CC       maintaining the laminin matrix (PubMed:23862019). Required in the
CC       developing wing to regulate extracellular matrix (ECM) organization by
CC       activating the cGMP-dependent protein kinase For which represses the
CC       activity of matrix metalloproteases such as Mmp2 and decreases ECM
CC       matrix reorganization (PubMed:26440503). {ECO:0000269|PubMed:15282266,
CC       ECO:0000269|PubMed:21893139, ECO:0000269|PubMed:23213443,
CC       ECO:0000269|PubMed:23862019, ECO:0000269|PubMed:24284209,
CC       ECO:0000269|PubMed:26440503}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP = 3',5'-cyclic GMP + diphosphate; Xref=Rhea:RHEA:13665,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:37565, ChEBI:CHEBI:57746; EC=4.6.1.2;
CC         Evidence={ECO:0000255, ECO:0000255|RuleBase:RU003431,
CC         ECO:0000269|PubMed:24284209};
CC   -!- SUBUNIT: Interacts with the semaphorin 1A receptor PlexA; PlexA
CC       enhances Gyc76C catalytic activity. Interacts with the PDZ domain-
CC       containing protein kermit; kermit increases cell surface expression of
CC       Gyc76C. {ECO:0000269|PubMed:24284209}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:24284209};
CC       Single-pass type I membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: In the adult, widely distributed in the head and
CC       thorax with highest levels in the optic lobe and central brain and
CC       expression also detected in the retina (PubMed:7759483). Expressed at
CC       similar levels in adult head and body (PubMed:7759483). In females,
CC       highly expressed in oocytes with lower levels in the digestive tract
CC       (PubMed:7759483). In mid-embryogenesis, enriched in the circular
CC       visceral mesoderm that overlies the migrating salivary gland and in the
CC       fat body that underlies the gland but at background levels in the gland
CC       itself (PubMed:23213443). In late embryogenesis, detected in the mature
CC       salivary gland, in the somatic body wall muscles and the tendon cells
CC       to which the muscles attach, and in the constricting midgut
CC       (PubMed:23213443). Also expressed in migrating tracheal cells at mid-
CC       embryogenesis and in the developed trachea at the end of embryogenesis
CC       with enrichment in the apical domains (PubMed:23213443).
CC       {ECO:0000269|PubMed:23213443, ECO:0000269|PubMed:7759483}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in embryo, larva, pupa and adult
CC       (PubMed:7706258, PubMed:7759483). Expressed at very high levels in
CC       early cleavage stage embryos at 0-2 hours followed by lower expression
CC       at 2-6 and 6-10 hours of embryogenesis (PubMed:7706258). During later
CC       stages of embryogenesis at 10-14 and 14-18 hours, expressed again at
CC       high levels, particularly in muscle fibers (PubMed:7706258). Very low
CC       levels in larval and pupal stages (PubMed:7706258).
CC       {ECO:0000269|PubMed:7706258, ECO:0000269|PubMed:7759483}.
CC   -!- DOMAIN: The guanylate cyclase domain is required for Sema-1a-mediated
CC       axon repulsion. {ECO:0000269|PubMed:15282266}.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- DISRUPTION PHENOTYPE: Abnormal patterning of the somatic body wall
CC       muscles with numerous ventral and lateral muscles that fail to extend
CC       or are missing and reduced levels of integrin beta-ps at dorsal muscle
CC       myotendinous junctions (PubMed:23213443). Defects in salivary gland
CC       invagination, migration and lumen shape and mislocalization of the
CC       integrin-binding protein rhea/Talin (PubMed:23862019). Defects in motor
CC       axon guidance with failure of motor axons to defasciculate from one
CC       another and innervate their proper muscle targets (PubMed:15282266).
CC       Wings display disrupted posterior crossveins (PubMed:26440503). RNAi-
CC       mediated knockdown in malpighian tubule principal cells inhibits NPLP1-
CC       4-mediated increases in fluid transport rates and cGMP levels, inhibits
CC       NPLP1-4-mediated nuclear translocation of NF-kappa-B protein Rel and
CC       abolishes expression of the antimicrobial peptide diptericin
CC       (PubMed:21893139). {ECO:0000269|PubMed:15282266,
CC       ECO:0000269|PubMed:21893139, ECO:0000269|PubMed:23213443,
CC       ECO:0000269|PubMed:23862019, ECO:0000269|PubMed:26440503}.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl cyclase
CC       family. {ECO:0000255, ECO:0000255|RuleBase:RU000405}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L35598; AAA74408.1; -; mRNA.
DR   EMBL; U23485; AAA85858.1; -; mRNA.
DR   EMBL; AE014296; ACZ94744.1; -; Genomic_DNA.
DR   EMBL; AE014296; ACZ94745.1; -; Genomic_DNA.
DR   EMBL; AE014296; ACZ94746.1; -; Genomic_DNA.
DR   EMBL; AE014296; AGB94756.1; -; Genomic_DNA.
DR   EMBL; BT011062; AAR31133.1; -; mRNA.
DR   PIR; A56699; A56699.
DR   RefSeq; NP_001007096.1; NM_001007095.3.
DR   RefSeq; NP_001007097.1; NM_001007096.3.
DR   RefSeq; NP_001163473.1; NM_001170002.1.
DR   RefSeq; NP_001163474.1; NM_001170003.2.
DR   RefSeq; NP_001163475.1; NM_001170004.2.
DR   RefSeq; NP_001262063.1; NM_001275134.1.
DR   RefSeq; NP_524165.2; NM_079441.4.
DR   SMR; Q7JQ32; -.
DR   IntAct; Q7JQ32; 8.
DR   STRING; 7227.FBpp0291487; -.
DR   PaxDb; Q7JQ32; -.
DR   PRIDE; Q7JQ32; -.
DR   EnsemblMetazoa; FBtr0302277; FBpp0291483; FBgn0261360.
DR   EnsemblMetazoa; FBtr0302278; FBpp0291484; FBgn0261360.
DR   EnsemblMetazoa; FBtr0302279; FBpp0291485; FBgn0261360.
DR   EnsemblMetazoa; FBtr0302280; FBpp0291486; FBgn0266136.
DR   EnsemblMetazoa; FBtr0302281; FBpp0291487; FBgn0266136.
DR   EnsemblMetazoa; FBtr0302282; FBpp0291488; FBgn0266136.
DR   EnsemblMetazoa; FBtr0333879; FBpp0306011; FBgn0266136.
DR   GeneID; 40153; -.
DR   GeneID; 8674026; -.
DR   KEGG; dme:Dmel_CG42636; -.
DR   KEGG; dme:Dmel_CG42637; -.
DR   CTD; 8674026; -.
DR   FlyBase; FBgn0266136; Gyc76C.
DR   eggNOG; KOG1023; Eukaryota.
DR   GeneTree; ENSGT00940000168507; -.
DR   HOGENOM; CLU_001072_1_1_1; -.
DR   InParanoid; Q7JQ32; -.
DR   OMA; NINSFHG; -.
DR   OrthoDB; 229634at2759; -.
DR   PhylomeDB; Q7JQ32; -.
DR   ChiTaRS; Gyc76C; fly.
DR   PRO; PR:Q7JQ32; -.
DR   Proteomes; UP000000803; Chromosome 3L.
DR   Bgee; FBgn0261360; Expressed in arthropod fat body and 18 other tissues.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:FlyBase.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004383; F:guanylate cyclase activity; IDA:FlyBase.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0001653; F:peptide receptor activity; IPI:FlyBase.
DR   GO; GO:0030215; F:semaphorin receptor binding; IPI:FlyBase.
DR   GO; GO:0038023; F:signaling receptor activity; IDA:FlyBase.
DR   GO; GO:0007411; P:axon guidance; IGI:FlyBase.
DR   GO; GO:0016199; P:axon midline choice point recognition; IGI:FlyBase.
DR   GO; GO:0006182; P:cGMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0030198; P:extracellular matrix organization; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0007526; P:larval somatic muscle development; IMP:FlyBase.
DR   GO; GO:0008045; P:motor neuron axon guidance; IMP:FlyBase.
DR   GO; GO:0007428; P:primary branching, open tracheal system; IMP:FlyBase.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   GO; GO:0007168; P:receptor guanylyl cyclase signaling pathway; IDA:FlyBase.
DR   GO; GO:0030510; P:regulation of BMP signaling pathway; IMP:UniProtKB.
DR   GO; GO:0009651; P:response to salt stress; IMP:FlyBase.
DR   GO; GO:0007435; P:salivary gland morphogenesis; IMP:FlyBase.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   CDD; cd07302; CHD; 1.
DR   Gene3D; 3.30.70.1230; -; 1.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00211; Guanylate_cyc; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   SMART; SM00044; CYCc; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
DR   SUPFAM; SSF55073; SSF55073; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 1.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; cGMP biosynthesis; Glycoprotein; GTP-binding;
KW   Lyase; Magnesium; Membrane; Metal-binding; Nucleotide-binding; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..1525
FT                   /note="Receptor-type guanylate cyclase Gyc76C"
FT                   /id="PRO_5007213161"
FT   TOPO_DOM        20..493
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        494..514
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        515..1525
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          547..824
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          896..1026
FT                   /note="Guanylate cyclase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   NP_BIND         553..561
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   METAL           901
FT                   /note="Magnesium 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   METAL           901
FT                   /note="Magnesium 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   METAL           902
FT                   /note="Magnesium 2; via carbonyl oxygen"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   METAL           945
FT                   /note="Magnesium 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   METAL           945
FT                   /note="Magnesium 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         581
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   CARBOHYD        74
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        184
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        222
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        338
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        383
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        394
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        416
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        428
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        458
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   MUTAGEN         635
FT                   /note="L->H: In 3L043; complete loss of the posterior
FT                   crossvein in adult wings."
FT                   /evidence="ECO:0000269|PubMed:26440503"
FT   MUTAGEN         945
FT                   /note="D->A: Abolishes guanylate cyclase activity but does
FT                   not affect cell surface location."
FT                   /evidence="ECO:0000269|PubMed:24284209"
FT   CONFLICT        381
FT                   /note="A -> S (in Ref. 2; AAA85858)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1525 AA;  170503 MW;  5055D253FD398D30 CRC64;
     MTRWPFNLLL LLSVAVRDCS NHRTVLTVGY LTALTGDLKT RQGLAISGAL TMALDEVNKD
     PNLLPNVYLD LRWNDTKGDT VLATKAITEM ICDGIATIFG PEGPCYVEAI VSQSRNIPMI
     SYKCAEYRAS AIPTFARTEP PDTQVVKSLL ALLRYYAWNK FSILYEDVWS PVADLLKDQA
     TKRNMTINHK QSFIDNRVKC CEQMLDCCRS GYWYQLVQNT MNRTRIYVFL GAANSLVDFM
     SSMETAGLFA RGEYMVIFVD MMVYSEREAE KYLRRVDQIT FMSNCHSTEN FNQMARSLLV
     VASTPPTKDY IQFTKQVQKY SSKPPFNLEI PRLFVESNFS KFISIYAAYL YDSVKLYAWA
     VDKMLREETR VLTDDVIFEV ASNGTRVIDT IIKNRTYMSI TGSKIKIDQY GDSEGNFSVL
     AYKPHKWNNS NNMPCNYHMV PVAYFHQGEE HPEYKLINGS IDWPSGGEKP ADEPMCGFAN
     ELCKKDDTHY TSTVAAVVLG VLLFCSGVIT MSIYRKWKIE LEIEGLLWKI DPNEIKGYSG
     NEIVSSPSKV SLMSAQSYGS RWTNQFVTST GRLRGAVVRI KELKFPRKRD ISREIMKEMR
     LLRELRHDNI NSFIGASVEP TRILLVTDYC AKGSLYDIIE NEDIKLDDLF IASLIHDLIK
     GMIYIHNSQL VYHGNLKSSN CVVTSRWMLQ VTDFGLHELR QCAENESIGE HQHYRNQLWR
     APELLRNHIH GSQKGDVYAF AIIMYEIFSR KGPFGQINFE PKEIVDYVKK LPLKGEDPFR
     PEVESIIEAE SCPDYVLACI RDCWAEDPEE RPEFSVIRNR LKKMRGGKTK NIMDQMMEMM
     EKYANNLEDI VTERTRLLCE EKMKTEDLLH RMLPQSVAEK LTMGQGVEPV SYDLVTIYFS
     DIVGFTAMSA ESTPLQVVNF LNDLYTVFDR IIRGYDVYKV ETIGDAYMVV SGLPIKNGDR
     HAGEIASMAL ELLHAVKQHR IAHRPNETLK LRIGMHTGPV VAGVVGLTMP RYCLFGDTVN
     TASRMESNGE ALKIHISNKC KLALDKLGGG YITEKRGLVN MKGKGDVVTW WLTGANENAI
     QKKLVDMMDM PPPLFSRPRK SPKLNPDSRQ PSIQAMHFCG TGSRRQSTVP RAMDGESTYS
     LQGSVRESPR MVSKRDRDRE RPPINGLGAG HFVGGALLES AQASLSTLNH SETNETNCDM
     DGGSGGVSGS GSGLVRQPNA LHKPLAMVRP HRIISAAQLP QLGDNDDDSA DTLLRESRSL
     DPMPMQQLRK RHDRVKLPPS KLSKNNSRSL DTGVSLISGN PNGEVHSSQL DLDNEMTANP
     VDATDGYDDE LGLLMRHDNG QLPALRYSGS FPNAQISIVP TGRSAGGGGG GREGGGSNCA
     KHLNNNCNGG VNVEDDLESP LLQRQASLSV PPEEMLAHNK RWHSLEHMDG PGGHGGNSVS
     YAADIDNRHP GDLDFFSGSS NQHHRSKAAG GSKLTNWMTN IFKGNGVRSG EARRVGILPS
     GVHGARTGFT DMAASAAARD RESIV
//
